Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | KD033 |
Trade Name | |
Synonyms | KD 033|KD-033 |
Drug Descriptions |
KD033 is a fusion protein consisting of a PD-L1 (CD274) antibody fused to human IL-15, which potentially results in increased T-cell tumor infiltration and inhibition of tumor growth (J Clin Oncol 39, no. 15_suppl.e14556; J Clin Oncol 39, no. 15_suppl (May 20, 2021) 2568). |
DrugClasses | Immune Checkpoint Inhibitor 147 PD-L1/PD-1 antibody 117 |
CAS Registry Number | NA |
NCIT ID | C173592 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
KD033 | KD033 | 0 | 1 |